Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |